Curaleaf Holdings Inc
CNSX:CURA
Intrinsic Value
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. [ Read More ]
The intrinsic value of one CURA stock under the Base Case scenario is 4.82 CAD. Compared to the current market price of 6.59 CAD, Curaleaf Holdings Inc is Overvalued by 27%.
Valuation Backtest
Curaleaf Holdings Inc
Run backtest to discover the historical profit from buying and selling CURA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Curaleaf Holdings Inc
| Current Assets | 483.8m |
| Cash & Short-Term Investments | 118.1m |
| Receivables | 43.8m |
| Other Current Assets | 321.9m |
| Non-Current Assets | 2.7B |
| Long-Term Investments | 2.5m |
| PP&E | 836m |
| Intangibles | 1.9B |
| Other Non-Current Assets | 48m |
| Current Liabilities | 556.2m |
| Accounts Payable | 63.7m |
| Accrued Liabilities | 118m |
| Other Current Liabilities | 374.5m |
| Non-Current Liabilities | 1.6B |
| Long-Term Debt | 884.9m |
| Other Non-Current Liabilities | 692.7m |
Earnings Waterfall
Curaleaf Holdings Inc
|
Revenue
|
2.3B
USD
|
|
Cost of Revenue
|
-1.3B
USD
|
|
Gross Profit
|
1B
USD
|
|
Operating Expenses
|
-1B
USD
|
|
Operating Income
|
12.2m
USD
|
|
Other Expenses
|
-600.3m
USD
|
|
Net Income
|
-588.1m
USD
|
Free Cash Flow Analysis
Curaleaf Holdings Inc
CURA Profitability Score
Profitability Due Diligence
Curaleaf Holdings Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Curaleaf Holdings Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
CURA Solvency Score
Solvency Due Diligence
Curaleaf Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Curaleaf Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CURA Price Targets Summary
Curaleaf Holdings Inc
According to Wall Street analysts, the average 1-year price target for CURA is 8.5 CAD .
Shareholder Return
CURA Price
Curaleaf Holdings Inc
| Average Annual Return | -6.03% |
| Standard Deviation of Annual Returns | 74.69% |
| Max Drawdown | -86% |
| Market Capitalization | 4.8B CAD |
| Shares Outstanding | 726 332 264 |
| Percentage of Shares Shorted | 0.1% |
CURA News
Last Important Events
Curaleaf Holdings Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Curaleaf Holdings Inc
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. The company is headquartered in Vancouver, British Columbia and currently employs 5,138 full-time employees. The company went IPO on 2015-10-22. The firm improves lives by providing cannabis for consumption. The firm and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The firm operates in 23 states with 123 dispensaries and 25 cultivation sites. The company focuses on populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. The firm's brands also include Curaleaf Hemp and UKU Cannabis. Curaleaf is a national retail dispensary brand in the United States, which is available in multiple states and product formats.
Contact
IPO
Employees
Officers
The intrinsic value of one CURA stock under the Base Case scenario is 4.82 CAD.
Compared to the current market price of 6.59 CAD, Curaleaf Holdings Inc is Overvalued by 27%.
You don't have any saved screeners yet
